vs
Apellis Pharmaceuticals, Inc.（APLS）与KITE REALTY GROUP TRUST（KRG）财务数据对比。点击上方公司名可切换其他公司
KITE REALTY GROUP TRUST的季度营收约是Apellis Pharmaceuticals, Inc.的1.0倍（$200.7M vs $199.9M），KITE REALTY GROUP TRUST净利率更高（0.2% vs -29.5%，领先29.7%），Apellis Pharmaceuticals, Inc.同比增速更快（-5.9% vs -9.2%），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -2.8%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Kite Realty Group Trust是一家总部位于美国的上市房地产投资信托，主要持有、运营及开发露天购物中心与混合用途物业，资产组合覆盖美国多个核心区域市场，租户包括全国连锁零售品牌、本地独立商户及餐饮娱乐运营商，服务当地社区消费需求。
APLS vs KRG — 直观对比
营收规模更大
KRG
是对方的1.0倍
$199.9M
营收增速更快
APLS
高出3.3%
-9.2%
净利率更高
KRG
高出29.7%
-29.5%
两年增速更快
APLS
近两年复合增速
-2.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $200.7M |
| 净利润 | $-59.0M | $330.0K |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | — |
| 净利率 | -29.5% | 0.2% |
| 营收同比 | -5.9% | -9.2% |
| 净利润同比 | -62.2% | -51.6% |
| 每股收益（稀释后） | $-0.40 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSKRG
| Q1 26 | — | $200.7M | ||
| Q4 25 | $199.9M | $204.2M | ||
| Q3 25 | $458.6M | $205.1M | ||
| Q2 25 | $178.5M | $213.4M | ||
| Q1 25 | $166.8M | $221.8M | ||
| Q4 24 | $212.5M | $214.7M | ||
| Q3 24 | $196.8M | $207.3M | ||
| Q2 24 | $199.7M | $212.4M |
净利润APLSKRG
| Q1 26 | — | $330.0K | ||
| Q4 25 | $-59.0M | $180.8M | ||
| Q3 25 | $215.7M | $-16.2M | ||
| Q2 25 | $-42.2M | $110.3M | ||
| Q1 25 | $-92.2M | $23.7M | ||
| Q4 24 | $-36.4M | $21.8M | ||
| Q3 24 | $-57.4M | $16.7M | ||
| Q2 24 | $-37.7M | $-48.6M |
营业利润率APLSKRG
| Q1 26 | — | — | ||
| Q4 25 | -25.6% | — | ||
| Q3 25 | 48.7% | — | ||
| Q2 25 | -18.6% | — | ||
| Q1 25 | -50.0% | 24.2% | ||
| Q4 24 | -12.3% | 23.0% | ||
| Q3 24 | -24.0% | 21.7% | ||
| Q2 24 | -14.7% | -10.5% |
净利率APLSKRG
| Q1 26 | — | 0.2% | ||
| Q4 25 | -29.5% | 88.6% | ||
| Q3 25 | 47.0% | -7.9% | ||
| Q2 25 | -23.6% | 51.7% | ||
| Q1 25 | -55.3% | 10.7% | ||
| Q4 24 | -17.1% | 10.2% | ||
| Q3 24 | -29.2% | 8.1% | ||
| Q2 24 | -18.9% | -22.9% |
每股收益（稀释后）APLSKRG
| Q1 26 | — | $0.06 | ||
| Q4 25 | $-0.40 | $0.83 | ||
| Q3 25 | $1.67 | $-0.07 | ||
| Q2 25 | $-0.33 | $0.50 | ||
| Q1 25 | $-0.74 | $0.11 | ||
| Q4 24 | $-0.30 | $0.10 | ||
| Q3 24 | $-0.46 | $0.08 | ||
| Q2 24 | $-0.30 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $32.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $2.9B |
| 总资产 | $1.1B | $6.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSKRG
| Q1 26 | — | $32.5M | ||
| Q4 25 | $466.2M | $36.8M | ||
| Q3 25 | $479.2M | $68.7M | ||
| Q2 25 | $370.0M | $182.0M | ||
| Q1 25 | $358.4M | $49.1M | ||
| Q4 24 | $411.3M | $478.1M | ||
| Q3 24 | $396.9M | $467.5M | ||
| Q2 24 | $360.1M | $273.8M |
总债务APLSKRG
| Q1 26 | — | — | ||
| Q4 25 | — | $3.0B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | — | $3.0B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | — | $3.2B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | — | $3.0B |
股东权益APLSKRG
| Q1 26 | — | $2.9B | ||
| Q4 25 | $370.1M | $3.1B | ||
| Q3 25 | $401.2M | $3.2B | ||
| Q2 25 | $156.3M | $3.3B | ||
| Q1 25 | $164.2M | $3.3B | ||
| Q4 24 | $228.5M | $3.3B | ||
| Q3 24 | $237.1M | $3.3B | ||
| Q2 24 | $264.3M | $3.4B |
总资产APLSKRG
| Q1 26 | — | $6.4B | ||
| Q4 25 | $1.1B | $6.7B | ||
| Q3 25 | $1.1B | $6.6B | ||
| Q2 25 | $821.4M | $6.9B | ||
| Q1 25 | $807.3M | $6.7B | ||
| Q4 24 | $885.1M | $7.1B | ||
| Q3 24 | $901.9M | $7.1B | ||
| Q2 24 | $904.5M | $7.0B |
负债/权益比APLSKRG
| Q1 26 | — | — | ||
| Q4 25 | — | 0.98× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | — | 0.89× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 0.97× | ||
| Q2 24 | — | 0.88× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | — |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | 3.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSKRG
| Q1 26 | — | — | ||
| Q4 25 | $-14.2M | $106.6M | ||
| Q3 25 | $108.5M | $116.2M | ||
| Q2 25 | $4.4M | $132.8M | ||
| Q1 25 | $-53.4M | $74.1M | ||
| Q4 24 | $19.4M | $111.0M | ||
| Q3 24 | $34.1M | $112.4M | ||
| Q2 24 | $-8.3M | $142.1M |
自由现金流APLSKRG
| Q1 26 | — | — | ||
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-8.4M | — |
自由现金流率APLSKRG
| Q1 26 | — | — | ||
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | -32.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.2% | — |
资本支出强度APLSKRG
| Q1 26 | — | 3.3% | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — |
现金转化率APLSKRG
| Q1 26 | — | — | ||
| Q4 25 | — | 0.59× | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | 1.20× | ||
| Q1 25 | — | 3.12× | ||
| Q4 24 | — | 5.09× | ||
| Q3 24 | — | 6.72× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
KRG
| Rental income | $198.0M | 99% |
| Fee income | $1.3M | 1% |
